Likewise, the relatively low intensity 922.50 m/z peak in MALDI-MSI of high-risk neuroblastomas is a tryptic peptide from CRMP1, a marker for neuronal differentiation that is involved in neuronal outgrowth and guidance. Here, CRMP1 is linked to neuroblastoma.